ICLR

ICON PLC

ICLR, USA

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

https://www.iconplc.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ICLR
stock
ICLR

Barclays Raises Price Target for ICLR to $200 | ICLR Stock News GuruFocus

Read more →
ICLR
stock
ICLR

Bank of America Downgrades Icon (NASDAQ:ICLR) to Neutral MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$206.1875

Analyst Picks

Strong Buy

11

Buy

0

Hold

6

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

24.93

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Low

1.56

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

0.03 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.01 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

17.23 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Low

0.77

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 86.56% of the total shares of ICON PLC

1.

Artisan Partners Limited Partnership

(9.2384%)

since

2025/06/30

2.

Artisan International Value Investor

(6.9042%)

since

2025/06/30

3.

Artisan International Value

(6.9042%)

since

2025/06/30

4.

Massachusetts Financial Services Company

(4.8244%)

since

2025/06/30

5.

Wellington Management Company LLP

(4.7085%)

since

2025/06/30

6.

Amvescap Plc.

(3.968%)

since

2025/06/30

7.

Ninety One UK Limited

(3.8493%)

since

2025/06/30

8.

D. E. Shaw & Co LP

(3.1297%)

since

2025/06/30

9.

Franklin Resources Inc

(2.6156%)

since

2025/06/30

10.

FMR Inc

(2.5259%)

since

2025/06/30

11.

Citadel Advisors Llc

(2.5024%)

since

2025/06/30

12.

Ruane, Cunniff & Goldfarb L.P.

(2.1964%)

since

2025/06/30

13.

Harris Associates L.P.

(2.1062%)

since

2025/06/30

14.

AllianceBernstein L.P.

(1.6982%)

since

2025/06/30

15.

Ninety One Global Franchise

(1.6022%)

since

2025/03/31

16.

Ninety One GSF Glb Frchs I Acc USD

(1.6022%)

since

2025/05/31

17.

T. Rowe Price Associates, Inc.

(1.527%)

since

2025/06/30

18.

1832 Asset Management L.P

(1.4804%)

since

2025/06/30

19.

ClearBridge Advisors, LLC

(1.4762%)

since

2025/06/30

20.

NORGES BANK

(1.4024%)

since

2025/06/30

21.

Comgest Global Investors SAS

(1.3692%)

since

2025/06/30

22.

Allspring Global Investments Holdings, LLC

(1.3636%)

since

2025/06/30

23.

UBS Group AG

(1.2591%)

since

2025/06/30

24.

First Pacific Advisors, LP

(1.2397%)

since

2025/06/30

25.

Principal International Eq Fd - Gross

(1.1866%)

since

2025/07/31

26.

Vanguard Windsor Investor Shares

(1.1514%)

since

2025/06/30

27.

Allspring Special Mid Cap Value Inst

(1.1405%)

since

2025/07/31

28.

Allspring Special US Mid Cap Value Eq

(1.1138%)

since

2025/06/30

29.

Allspring Mid Value SMA

(1.1138%)

since

2025/06/30

30.

T. Rowe Price US All-Cap Opp Eq Comp

(1.0331%)

since

2025/06/30

31.

Invesco Small Cap Value A

(0.9182%)

since

2025/07/31

32.

Oakmark Select Investor

(0.8911%)

since

2025/06/30

33.

Templeton Growth A

(0.8443%)

since

2025/07/31

34.

Baron Opp. Small Cap Growth Strategy

(0.8358%)

since

2025/06/30

35.

Baron Small Cap Retail

(0.8358%)

since

2025/06/30

36.

FMI International Investor

(0.8165%)

since

2025/06/30

37.

Fiduciary Mgt of Milwaukee Intl Comp

(0.8165%)

since

2025/06/30

38.

Sequoia

(0.8107%)

since

2025/06/30

39.

Templeton Growth (Euro) I(acc)EUR

(0.8036%)

since

2025/07/31

40.

Fidelity Low-Priced Stock

(0.7567%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

3.31

EPS Estimate

3.32

EPS Difference

-0.01

Surprise Percent

-0.3012%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
Strong Momentum(6.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(6)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.